DB05211ExperimentalSmall molecule
PS386113 is a small molecule drug candidate under investigation for the treatment of inflammatory disorders. It is being developed by Schering-Plough and Pharmacopeia. Little information has been released about PS386113.
- Primary indication
- For the treatment of inflammatory disease.Curator reviewed
- Code names
- PS386113
Which companies are running trials of PS386113, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account